EUVIMEDSkopri EUVIMED
EUVIMED · CrossrefJournal

Alcohol, Clinical and Experimental Research

ISSN 2993-7175 · Wiley

Latest articles

  1. Global Prognostic Impact of Substance Use in Alcohol‐Associated Hepatitis

    Omar Albhaisi, Francisco Idalsoaga, Wei Wang, Roberta C. Araujo, Guilherme Massote Fontanini, Arun Valsan, Gowripriya Nair, Bastián Alcayaga, Jorge Arnold, María Ayala‐Valverde, Carolina Ramirez‐Cadiz, Hanna Blaney, Vinay Jahagirdar, Hyundam Gu, S. Fisher Rhoads, Ximena Parraga, Butros Fakhoury, Prasun K. Jalal, Mohamad Ali Ibrahim, Mohamad A. Elfeki, Juan Pablo Roblero, Daniela Simian, José Antonio Velarde‐Ruiz Velasco, Jacqueline Córdova, Fátima Higuera‐de‐la‐Tijera, Rita Silva, Cristina Melo Rocha, Gustavo Henrique Pereira, Fernando Bessone, Mario Tanno, Ayelen Kisch, Manuel Mendizabal, Sebastián Marciano, Gonzalo Gomez Perdiguero, Pedro Montes, Patricia Guerra Salazar, Geraldine Ramos, Enrique Carrera, Lamia Haque, Kristina R. Chacko

    Published: 2026-11DOI: 10.1111/acer.70397

  2. Genetic Correlates of Treatment Utilization for Alcohol Use Disorder: A Family‐Based and Polygenic Investigation

    Kellyn M. Spychala, Christina E. Garasky, Margaret L. Clapp Sullivan, Emma C. Johnson, Jodi Kutzner, Dongbing Lai, Zeal Jinwala, Alex P. Miller, Danielle M. Dick, Jill A. Rabinowitz, Sally I‐Chun Kuo, John Nurnberger, Martin H. Plawecki, Ashwini K. Pandey, Grace Chan, Genevieve F. Dash, Sivan Kinreich, Marc Schuckit, Fanghong Dong, Victor Hesselbrock, Bernice Porjesz, Kathleen K. Bucholz, Vivia V. McCutcheon, Ryan Bogdan, Arpana Agrawal

    Published: 2026-11DOI: 10.1111/acer.70435

Volumes

2026 · 1652025 · 2712024 · 2462023 · 243

Għarfien li jaqbel max-xogħol tiegħek.

Minn bidu b’xejn u riċerka personali tal-letteratura sal-Research Suite sħiħa.

Ara t-tariffi →

Il-full texts kollha tal-pubblikaturi huma inklużi?

Le. Ir-referenzi biblijografiċi, l-astratti u t-testi sħaħ huma kontenuti differenti. Jekk test sħiħ huwiex disponibbli jiddependi mis-sors, Open Access u l-liċenzji eżistenti tiegħek. Pjan ta’ EUVIMED ma jissostitwix drittijiet addizzjonali tal-pubblikaturi.